| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3e43db17388a177fbbc72ebd82814c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aeae76b4fe6e60b604b73d339c3aefff |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 |
| filingDate |
1992-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a24ecffa74c41bf2b66e23256a42200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fee15959f6e298788fb5177cbb7401ab |
| publicationDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2067454-C1 |
| titleOfInvention |
Method of hemodynamic correction in newborns after hypoxia |
| abstract |
FIELD: medicine, pediatrics. SUBSTANCE: method involves the intravenous administration of preparation cytomack at dose 0.5-1.0 ml 0.25% solution per 1 kg child body mass, every day for the first postnatal life days. EFFECT: improved myocardium contractility, simplified treatment, elimination of toxic effect. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2672918-C1 |
| priorityDate |
1992-12-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |